What can modelling tell us about the scale-up of lenacapavir for pre-exposure prophylaxis?
Modelling shows that it will be essential to complement lenacapavir with additional prevention options, testing and treatment. See “Meeting reports” at https://www.unaids.org/en/resources/publications/all for a description of models and tools to estimate potential impact and quantifications required for lenacapavir